Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  PFIZER INC
 2. Date of Event Requiring Statement (Month/Day/Year)
02/03/2017		 3. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ICUI]
(Last)
(First)
(Middle)
235 E 42ND ST, 		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

NEW YORK, NY 10017		 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 3,200,000
I
_ (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
PFIZER INC
235 E 42ND ST
NEW YORK, NY 10017		   X   X    
C.P. Pharmaceuticals International C.V.
C/O ITS GENERAL PARTNERS
235 E. 42ND ST
NEW YORK, NY 10017		     X    
Pfizer Production LLC
235 EAST 42ND STREET
NEW YORK, NY 10017		     X    
Pfizer Manufacturing LLC
235 EAST 42ND STREET
NEW YORK, NY 10017		     X    

Signatures

Pfizer Inc., By /s/ Susan Grant, Assistant Secretary 02/13/2017
**Signature of Reporting Person Date
Pfizer Production LLC, acting in its capacity as general partner of C.P. Pharmaceuticals International C.V. By /s/ Brian McMahon, Senior Vice President 02/13/2017
**Signature of Reporting Person Date
Pfizer Manufacturing LLC, acting in its capacity as general partner of C.P. Pharmaceuticals International C.V. By /s/ Colum Lane, Senior Vice President 02/13/2017
**Signature of Reporting Person Date
Pfizer Production LLC, By /s/Darren Welsh, Secretary 02/13/2017
**Signature of Reporting Person Date
Pfizer Manufacturing LLC, By /s/Darren Welsh, Secretary 02/13/2017
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These shares are owned directly by C.P. Pharmaceuticals International C.V. ("CPPI"), whose general partners are Pfizer Production LLC ("PPL") and Pfizer Manufacturing LLC ("PPM"). CPPI, PPL and PPM are indirect wholly-owned subsidiaries of Pfizer Inc. ("Pfizer"). Pfizer, PPL and PPM are indirect beneficial owners of the shares.
 
Remarks:
Reporting Owner Name/Address/Relationship to Issuer:  C.P. Pharmaceuticals International C.V. (CPPI), 235 E. 42nd, New York, NY 10017;10% Ownership; Pfizer Production LLC (PPL), 235 E. 42nd New York, NY 10017 10% Ownership*; Pfizer Manufacturing LLC (PML), 235 E. 42nd New York, NY 10017 10% Ownership*; Pfizer Inc., 235 E. 42nd New York, NY 10017 10% Ownership.
*Each of PPL and PML, as general partner of CPPI, disclaim ownership of securities held by CPPI except to the extent of any pecuniary interest therein.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.